Dicyclomine injection
Products billed under this code include Bentyl, Dicyclomine HCl.
Payment limit per 20 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Bentyl, Dicyclomine HCl.
Payment limit per 20 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Bentyl | A-S Medication Solutions | 50090-4553-00 | 1 | $12.061 |
| Bentyl | Allergan, Inc. | 58914-0080-52 | 5 | $60.305 |
| Dicyclomine HCl | American Regent, Inc. | 00517-1980-05 | 5 | $60.305 |
| Dicyclomine HCl | Hikma Pharmaceuticals USA Inc. | 00641-6173-10 | 10 | $120.61 |
| Dicyclomine HCl | Nexus Pharmaceuticals, LLC | 14789-0010-02 | 5 | $60.305 |
| Dicyclomine HCl | HF Acquisition Co. LLC, DBA HealthFirst | 51662-1559-03 | 5 | $60.305 |
| Dicyclomine HCl | FreseniUS Kabi USA, LLC | 63323-0842-02 | 5 | $60.305 |
| Dicyclomine HCl | Somerset Pharma, LLC | 70069-0431-05 | 5 | $60.305 |
| Dicyclomine HCl | Somerset Pharma, LLC | 70069-0441-05 | 5 | $60.305 |
| Dicyclomine HCl | Slate Run Pharmaceuticals | 70436-0147-81 | 5 | $60.305 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Dicyclomine HCl | Fosun Pharma USA Inc. | 72266-0127-05 | 5 | $60.305 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $12.061 | +$3.541 | 20 MG | Dicyclomine injection | v1, posted September 17, 2026 |
| 3Q26 | $8.52 | −$0.845 | 20 MG | Dicyclomine injection | v1, posted September 15, 2026 |
| 2Q26 | $9.365 | −$1.962 | 20 MG | Dicyclomine injection | v1, posted September 15, 2026 |
| 1Q26 | $11.327 | −$0.031 | 20 MG | Dicyclomine injection | v1, posted September 15, 2026 |
| 4Q25 | $11.358 | −$0.317 | 20 MG | Dicyclomine injection | v1, posted September 8, 2026 |
| 3Q25 | $11.675 | −$1.182 | 20 MG | Dicyclomine injection | v1, posted March 10, 2026 |
| 2Q25 | $12.857 | −$2.047 | 20 MG | Dicyclomine injection | v1, posted March 10, 2026 |
| 1Q25 | $14.904 | −$0.97 | 20 MG | Dicyclomine injection | v1, posted December 19, 2025 |
| 4Q24 | $15.874 | −$4.458 | 20 MG | Dicyclomine injection | v1, posted June 11, 2025 |
| 3Q24 | $20.332 | −$4.653 | 20 MG | Dicyclomine injection | v1, posted June 11, 2025 |
| 2Q24 | $24.985 | +$0.02 | 20 MG | Dicyclomine injection | v1, posted March 11, 2025 |
| 1Q24 | $24.965 | +$3.165 | 20 MG | Dicyclomine injection | v1, posted December 19, 2024 |
| 4Q23 | $21.80 | −$3.636 | 20 MG | Dicyclomine injection | v1, posted October 10, 2024 |
| 3Q23 | $25.436 | +$2.665 | 20 MG | Dicyclomine injection | v1, posted June 5, 2024 |
| 2Q23 | $22.771 | −$1.417 | 20 MG | Dicyclomine injection | v1, posted February 23, 2024 |
| 1Q23 | $24.188 | −$1.448 | 20 MG | Dicyclomine injection | v1, posted December 6, 2023 |
| 4Q22 | $25.636 | −$1.579 | 20 MG | Dicyclomine injection | v1, posted June 22, 2023 |
| 3Q22 | $27.215 | +$1.14 | 20 MG | Dicyclomine injection | v1, posted June 9, 2023 |
| 2Q22 | $26.075 | −$2.55 | 20 MG | Dicyclomine injection | v1, posted December 14, 2022 |
| 1Q22 | $28.625 | −$4.366 | 20 MG | Dicyclomine injection | v1, posted June 8, 2022 |
| 4Q21 | $32.991 | +$3.871 | 20 MG | Dicyclomine injection | v1, posted June 2, 2022 |
| 3Q21 | $29.12 | −$4.727 | 20 MG | Dicyclomine injection | v1, posted June 2, 2022 |
| 2Q21 | $33.847 | −$0.788 | 20 MG | Dicyclomine injection | v1, posted March 1, 2022 |
| 1Q21 | $34.635 | – | 20 MG | Dicyclomine injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.